Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
The investigation of a potential regulator of spermatogonial stem cell pool size for its application in oncofertility
FY 2013-14
Summary
As a result of the rising efficacy of cancer treatments, a novel facet of oncology has experienced a surge of scientific interest in recent years: oncofertility. Radio- and chemotherapy can obliterate the resident sperm precursors, called spermatogonia, giving rise to post-treatment infertility in survivors. The path toward fertility restoration is obscure in prepubescent males, who are understandably ineligible for sperm banking. The rescue of their fertility could possibly hinge upon our ability to conserve and expand their native germ stem cell population in a laboratory setting. However, the identification of spermatogonial stem cell (SSC)-specific biological markers currently poses a great hurdle, since none of the candidate markers have exceptionally identify SSCs to date. Effectively, definitive biomarkers for “stemness” are as of yet problematically undefined in many other adult stem cell populations; their elucidation in SSCs seemingly constitutes an equally insurmountable feat. The development of a cell culture (in vitro) system favouring SSC proliferation over their differentiation into mature sperm would circumvent the need for these elusive ""fate biomarkers"". Since spermatogonial cell fate determination is likely coordinated by the environment in which it is found, it is possible that, by way of a lateral inhibition-like mechanism, intercommunications between neighbouring spermatogonia could possibly hold them responsible for their own fate. Recent evidence points to a differential expression of Notch pathway components, known effectors of lateral inhibition signaling involved in the sustenance of stem cell pools, throughout the cycle of sperm production (spermatogenesis) in mice. Notably, delta-like ligand 4 (Dll4) expression is specific to spermatogonia in young mice, and conversely expressed exclusively by cells beginning to differentiate in pubertal mice. It is conceivable that, in early life, spermatogenesis is inhibited by an endogenous production of Dll4, until puberty where the differentiating spermatogonia maintain the stem cell pool by laterally inhibiting further SSC differentiation. To test this theory, I would first derive a germline stem (GS) cell line from spermatogonia of neonatal mice, following a procedure outlined by Katanatsu-Shinohara et al. in 2004, because these cells high resemble adult SSCs. I would verify the constitutive Dll4 expression levels as well as the effect of Dll4 abolition on cell proliferation. If Dll4 appeared to have a critical role in the maintenance of the stem cell culture, I would then proceed to study Dll4 and spermatogonial proliferation in mice (in vivo analyses). If both the in vitro and in vivo experiments indicate a strong correlation between Dll4 and SSC self-renewal, a stem cell culture system preferentially promoting adult mouse SSC proliferation could be optimized, with Dll4 comprising one of its essential components. The findings of my proposed study could ideally be extrapolated to human SSC culture expansion, and therefore contribute to the advancement of the field of oncofertility.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311680
Name
Vlasschaert Caitlyn
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The investigation of a potential regulator of spermatogonial stem cell pool size for its application in oncofertility
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Delta-Like Ligand 4; Differentiation; Lateral Inhibition; Male Infertility; Niche; Notch; Oncofertility; Self-Renewal; Spermatogonia; Stem Cell
Abstract
As a result of the rising efficacy of cancer treatments, a novel facet of oncology has experienced a surge of scientific interest in recent years: oncofertility. Radio- and chemotherapy can obliterate the resident sperm precursors, called spermatogonia, giving rise to post-treatment infertility in survivors. The path toward fertility restoration is obscure in prepubescent males, who are understandably ineligible for sperm banking. The rescue of their fertility could possibly hinge upon our ability to conserve and expand their native germ stem cell population in a laboratory setting. However, the identification of spermatogonial stem cell (SSC)-specific biological markers currently poses a great hurdle, since none of the candidate markers have exceptionally identify SSCs to date. Effectively, definitive biomarkers for “stemness” are as of yet problematically undefined in many other adult stem cell populations; their elucidation in SSCs seemingly constitutes an equally insurmountable feat. The development of a cell culture (in vitro) system favouring SSC proliferation over their differentiation into mature sperm would circumvent the need for these elusive ""fate biomarkers"". Since spermatogonial cell fate determination is likely coordinated by the environment in which it is found, it is possible that, by way of a lateral inhibition-like mechanism, intercommunications between neighbouring spermatogonia could possibly hold them responsible for their own fate. Recent evidence points to a differential expression of Notch pathway components, known effectors of lateral inhibition signaling involved in the sustenance of stem cell pools, throughout the cycle of sperm production (spermatogenesis) in mice. Notably, delta-like ligand 4 (Dll4) expression is specific to spermatogonia in young mice, and conversely expressed exclusively by cells beginning to differentiate in pubertal mice. It is conceivable that, in early life, spermatogenesis is inhibited by an endogenous production of Dll4, until puberty where the differentiating spermatogonia maintain the stem cell pool by laterally inhibiting further SSC differentiation. To test this theory, I would first derive a germline stem (GS) cell line from spermatogonia of neonatal mice, following a procedure outlined by Katanatsu-Shinohara et al. in 2004, because these cells high resemble adult SSCs. I would verify the constitutive Dll4 expression levels as well as the effect of Dll4 abolition on cell proliferation. If Dll4 appeared to have a critical role in the maintenance of the stem cell culture, I would then proceed to study Dll4 and spermatogonial proliferation in mice (in vivo analyses). If both the in vitro and in vivo experiments indicate a strong correlation between Dll4 and SSC self-renewal, a stem cell culture system preferentially promoting adult mouse SSC proliferation could be optimized, with Dll4 comprising one of its essential components. The findings of my proposed study could ideally be extrapolated to human SSC culture expansion, and therefore contribute to the advancement of the field of oncofertility.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vlasschaert, Caitlyn
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~